Logo image of QSI

QUANTUM-SI INC (QSI) Stock Fundamental Analysis

NASDAQ:QSI - Nasdaq - US74765K1051 - Common Stock - Currency: USD

1.44  0 (0%)

After market: 1.3 -0.14 (-9.72%)

Fundamental Rating

3

QSI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 54 industry peers in the Life Sciences Tools & Services industry. QSI has a great financial health rating, but its profitability evaluates not so good. QSI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year QSI has reported negative net income.
QSI had a negative operating cash flow in the past year.
In the past 5 years QSI always reported negative net income.
QSI had a negative operating cash flow in each of the past 5 years.
QSI Yearly Net Income VS EBIT VS OCF VS FCFQSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

The Return On Assets of QSI (-37.14%) is worse than 79.63% of its industry peers.
QSI has a Return On Equity of -40.79%. This is in the lower half of the industry: QSI underperforms 68.52% of its industry peers.
Industry RankSector Rank
ROA -37.14%
ROE -40.79%
ROIC N/A
ROA(3y)-35.58%
ROA(5y)-43.16%
ROE(3y)-39.71%
ROE(5y)-48.09%
ROIC(3y)N/A
ROIC(5y)N/A
QSI Yearly ROA, ROE, ROICQSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 52.77%, QSI is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
QSI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QSI Yearly Profit, Operating, Gross MarginsQSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

8

2. Health

2.1 Basic Checks

QSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, QSI has more shares outstanding
There is no outstanding debt for QSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
QSI Yearly Shares OutstandingQSI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
QSI Yearly Total Debt VS Total AssetsQSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 3.70 indicates that QSI is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.70, QSI is in the better half of the industry, outperforming 74.07% of the companies in the same industry.
There is no outstanding debt for QSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.7
ROIC/WACCN/A
WACC10.25%
QSI Yearly LT Debt VS Equity VS FCFQSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

QSI has a Current Ratio of 19.24. This indicates that QSI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 19.24, QSI belongs to the top of the industry, outperforming 98.15% of the companies in the same industry.
A Quick Ratio of 18.89 indicates that QSI has no problem at all paying its short term obligations.
QSI has a better Quick ratio (18.89) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 19.24
Quick Ratio 18.89
QSI Yearly Current Assets VS Current LiabilitesQSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for QSI have decreased by -4.62% in the last year.
The Revenue has grown by 167.52% in the past year. This is a very strong growth!
EPS 1Y (TTM)-4.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.43%
Revenue 1Y (TTM)167.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%84.25%

3.2 Future

The Earnings Per Share is expected to grow by 10.65% on average over the next years. This is quite good.
The Revenue is expected to grow by 123.57% on average over the next years. This is a very strong growth
EPS Next Y21.76%
EPS Next 2Y11.95%
EPS Next 3Y11.94%
EPS Next 5Y10.65%
Revenue Next Year94.56%
Revenue Next 2Y146.93%
Revenue Next 3Y149.37%
Revenue Next 5Y123.57%

3.3 Evolution

QSI Yearly Revenue VS EstimatesQSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
QSI Yearly EPS VS EstimatesQSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QSI. In the last year negative earnings were reported.
Also next year QSI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QSI Price Earnings VS Forward Price EarningsQSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QSI Per share dataQSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.95%
EPS Next 3Y11.94%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QSI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUANTUM-SI INC

NASDAQ:QSI (8/5/2025, 4:40:58 PM)

After market: 1.3 -0.14 (-9.72%)

1.44

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners30.88%
Inst Owner Change-1.55%
Ins Owners5.65%
Ins Owner Change8.23%
Market Cap290.45M
Analysts77.14
Price Target2.89 (100.69%)
Short Float %14.83%
Short Ratio2.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.49%
Min EPS beat(2)-21.99%
Max EPS beat(2)28.97%
EPS beat(4)3
Avg EPS beat(4)8.05%
Min EPS beat(4)-21.99%
Max EPS beat(4)28.97%
EPS beat(8)7
Avg EPS beat(8)12.15%
EPS beat(12)10
Avg EPS beat(12)8.65%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.91%
Min Revenue beat(2)-12.03%
Max Revenue beat(2)-3.79%
Revenue beat(4)0
Avg Revenue beat(4)-13.25%
Min Revenue beat(4)-27.8%
Max Revenue beat(4)-3.79%
Revenue beat(8)2
Avg Revenue beat(8)-13.59%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-16.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.67%
EPS NY rev (1m)0%
EPS NY rev (3m)9.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-23.95%
Revenue NY rev (1m)11.93%
Revenue NY rev (3m)-20.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 84.36
P/FCF N/A
P/OCF N/A
P/B 1.18
P/tB 1.18
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS0.02
BVpS1.22
TBVpS1.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.14%
ROE -40.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.77%
FCFM N/A
ROA(3y)-35.58%
ROA(5y)-43.16%
ROE(3y)-39.71%
ROE(5y)-48.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 108.71%
Cap/Sales 140.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 19.24
Quick Ratio 18.89
Altman-Z 3.7
F-Score4
WACC10.25%
ROIC/WACCN/A
Cap/Depr(3y)214.69%
Cap/Depr(5y)249.92%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.43%
EPS Next Y21.76%
EPS Next 2Y11.95%
EPS Next 3Y11.94%
EPS Next 5Y10.65%
Revenue 1Y (TTM)167.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%84.25%
Revenue Next Year94.56%
Revenue Next 2Y146.93%
Revenue Next 3Y149.37%
Revenue Next 5Y123.57%
EBIT growth 1Y-6.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year10.28%
EBIT Next 3Y5.81%
EBIT Next 5Y9.27%
FCF growth 1Y11.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.51%
OCF growth 3YN/A
OCF growth 5YN/A